Je was op zoek naar: decarboxylation (Engels - Deens)

carbidopa inhibits decarboxylation of peripheral levodopa.
carbidopa hæmmer decarboxylering af perifer levodopa.

the yields of heptadecadiene, derived from the related linoleic acid moiety by decarboxylation, are linearly dependent on the level of that specific fatty acid in the triglyceride.
mængderne af heptadecadien, som opstår ved decarboxylering af den beslægtede linolensyredel, er lineært afhængigt af indholdet af denne særlige fedtsyre i triglyceriden.

when decarboxylation of levodopa is reduced with the co-administration of a ddc inhibitor, a lower dose of levodopa can be used and the incidence of undesirable effects such as nausea is reduced.
når decarboxyleringen af levodopa reduceres ved samtidig administration af en ddc- hæmmer, kan en lavere dosis af levodopa benyttes, og forekomsten af uønskede virkninger så som kvalme reduceres.

levodopa is extensively metabolised to various metabolites, decarboxylation by dopa decarboxylase (ddc) and o-methylation by catechol-o-methyltransferase (comt) being the most important pathways.
levodopa metaboliseres i høj grad til forskellige metabolitter, hvor decarboxylering via dopadecarboxylase (ddc) og o- methylering via cathecol- o- methyltransferase (comt) er de vigtigste metaboliseringsveje.